BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23321669)

  • 21. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b).
    He J; Kallin EM; Tsukada Y; Zhang Y
    Nat Struct Mol Biol; 2008 Nov; 15(11):1169-75. PubMed ID: 18836456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function.
    Zhou Z; Yang X; He J; Liu J; Wu F; Yu S; Liu Y; Lin R; Liu H; Cui Y; Zhou C; Wang X; Wu J; Cao S; Guo L; Lin L; Wang T; Peng X; Qiang B; Hutchins AP; Pei D; Chen J
    Cell Rep; 2017 Nov; 21(8):2160-2170. PubMed ID: 29166607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia.
    He J; Nguyen AT; Zhang Y
    Blood; 2011 Apr; 117(14):3869-80. PubMed ID: 21310926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
    Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
    Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
    Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
    Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells.
    Galbiati A; Penzo M; Bacalini MG; Onofrillo C; Guerrieri AN; Garagnani P; Franceschi C; Treré D; Montanaro L
    Oncotarget; 2017 Jun; 8(23):37091-37103. PubMed ID: 28415746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of lysine (K)-specific demethylase 2B KDM2B inhibits glycolysis and induces autophagy in lung squamous cell carcinoma cells by regulating the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.
    Xie Z; Li H; Zang J
    Bioengineered; 2021 Dec; 12(2):12227-12235. PubMed ID: 34783291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation.
    Kwon DH; Kang JY; Joung H; Kim JY; Jeong A; Min HK; Shin S; Lee YG; Kim YK; Seo SB; Kook H
    Exp Mol Med; 2021 Feb; 53(2):250-263. PubMed ID: 33564100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors.
    Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y
    Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
    De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
    Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.
    Zacharopoulou N; Kallergi G; Alkahtani S; Tsapara A; Alarifi S; Schmid E; Sukkar B; Kampranis S; Lang F; Stournaras C
    Cancer Biol Ther; 2020 Jun; 21(6):533-540. PubMed ID: 32175798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
    Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
    Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
    Gillman ACT; Parker G; Allday MJ; Bazot Q
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.
    Kuang Y; Xu H; Lu F; Meng J; Yi Y; Yang H; Hou H; Wei H; Su S
    Cancer Sci; 2021 Jan; 112(1):231-242. PubMed ID: 33091189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.
    Kim JH; Lee J; Im SS; Kim B; Kim EY; Min HJ; Heo J; Chang EJ; Choi KC; Shin DM; Son J
    Exp Mol Med; 2024 Apr; 56(4):1013-1026. PubMed ID: 38684915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation and expression alterations of histone methylation-related NSD2, KDM2B and SETMAR genes in colon cancers.
    Moon SW; Son HJ; Mo HY; Choi EJ; Yoo NJ; Lee SH
    Pathol Res Pract; 2021 Mar; 219():153354. PubMed ID: 33621919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor Cells.
    Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Alkahtani S; Alarifi S; Tsichlis PN; Kampranis SC; Stournaras C
    Cell Physiol Biochem; 2018; 47(1):368-377. PubMed ID: 29772566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy.
    Karoopongse E; Yeung C; Byon J; Ramakrishnan A; Holman ZJ; Jiang PY; Yu Q; Deeg HJ; Marcondes AM
    PLoS One; 2014; 9(9):e107817. PubMed ID: 25225797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
    Yu X; Wang J; Wu J; Shi Y
    Mol Biosyst; 2015 Jul; 11(7):1867-75. PubMed ID: 25877602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.